{"schema_version":"secwatch.filing_event.v1","accession":"0001831283-22-000064","form_type":"8-K","ticker":"LIANY","cik":"0001831283","company_name":"LianBio","filed_at":"2022-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.497858+00:00","generated_at":"2026-06-23T04:09:27.493340+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"LianBio halts infigratinib CCA program after Helsinn exits US market","bullets":["Helsinn Healthcare SA permanently discontinues Truseltiq (infigratinib) in US; plans to withdraw NDA for business reasons.","BridgeBio closing global Phase 3 PROOF-301 trial of infigratinib in first-line cholangiocarcinoma (CCA).","LianBio terminating all CCA development in China; no longer pursuing infigratinib for CCA in licensed territories.","LianBio will continue supporting existing patients under the Hainan Named Patient Program.","LianBio expects to continue Phase 2a trial of infigratinib in gastric cancer and other FGFR-altered solid tumors."],"urls":{"canonical":"https://secwatch.observer/filing/0001831283-22-000064","json":"https://secwatch.observer/filing/0001831283-22-000064.json","markdown":"https://secwatch.observer/filing/0001831283-22-000064.md","text":"https://secwatch.observer/filing/0001831283-22-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831283/000183128322000064/0001831283-22-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831283/000183128322000064/lian-20221012.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:09:27.493340+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}